Rockwell Medical (RMTI) Competitors $1.02 -0.03 (-2.86%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.01 -0.01 (-0.49%) As of 08/15/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, IDXX, EW, and RMDShould you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), and ResMed (RMD). These companies are all part of the "health care equipment" industry. Rockwell Medical vs. Its Competitors ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed ReShape Lifesciences (NASDAQ:RSLS) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment. Do analysts rate RSLS or RMTI? Rockwell Medical has a consensus target price of $4.00, suggesting a potential upside of 292.16%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than ReShape Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has stronger valuation and earnings, RSLS or RMTI? Rockwell Medical has higher revenue and earnings than ReShape Lifesciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReShape Lifesciences$8.01M1.06-$7.13M-$108.27-0.03Rockwell Medical$101.49M0.34-$480KN/AN/A Does the media prefer RSLS or RMTI? In the previous week, Rockwell Medical had 3 more articles in the media than ReShape Lifesciences. MarketBeat recorded 17 mentions for Rockwell Medical and 14 mentions for ReShape Lifesciences. Rockwell Medical's average media sentiment score of 0.27 beat ReShape Lifesciences' score of 0.04 indicating that Rockwell Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ReShape Lifesciences 0 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rockwell Medical 0 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is RSLS or RMTI more profitable? Rockwell Medical has a net margin of -2.38% compared to ReShape Lifesciences' net margin of -69.71%. Rockwell Medical's return on equity of -6.75% beat ReShape Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets ReShape Lifesciences-69.71% -547.65% -79.89% Rockwell Medical -2.38%-6.75%-3.70% Which has more risk & volatility, RSLS or RMTI? ReShape Lifesciences has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. Do insiders and institutionals hold more shares of RSLS or RMTI? 22.1% of ReShape Lifesciences shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 0.0% of ReShape Lifesciences shares are owned by insiders. Comparatively, 3.6% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryRockwell Medical beats ReShape Lifesciences on 14 of the 16 factors compared between the two stocks. Get Rockwell Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMTI vs. The Competition Export to ExcelMetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.88M$10.61B$5.67B$9.82BDividend YieldN/A1.97%3.79%4.08%P/E Ratio-17.0019.7130.5825.12Price / Sales0.3431.56464.36116.51Price / Cash8.3124.3737.4059.05Price / Book1.013.399.096.18Net Income-$480K$209.94M$3.25B$264.89M7 Day Performance5.89%13.40%7.42%4.22%1 Month Performance-4.67%10.49%5.50%2.02%1 Year Performance-60.47%-10.07%30.67%24.22% Rockwell Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMTIRockwell Medical4.3189 of 5 stars$1.02-2.9%$4.00+292.2%-60.2%$35.88M$101.49M-17.00300Trending NewsEarnings ReportShort Interest ↓RSLSReShape Lifesciences0.1315 of 5 stars$1.88-16.1%N/A-98.8%$5.34M$8.01M-0.0150News CoverageEarnings ReportStock SplitGap DownABTAbbott Laboratories4.9289 of 5 stars$131.38-2.2%$144.47+10.0%+18.7%$233.71B$41.95B16.46114,000Positive NewsISRGIntuitive Surgical4.6698 of 5 stars$471.85+0.4%$595.95+26.3%+0.0%$168.51B$8.35B65.8115,638Positive NewsBSXBoston Scientific4.7482 of 5 stars$102.77-0.4%$117.50+14.3%+33.0%$152.83B$16.75B61.1753,000Positive NewsSYKStryker4.7875 of 5 stars$376.75-0.2%$430.10+14.2%+14.3%$144.35B$22.60B49.9053,000Positive NewsMDTMedtronic4.7875 of 5 stars$92.80-0.1%$98.19+5.8%+11.2%$119.05B$33.54B25.6395,000News CoveragePositive NewsUpcoming EarningsDividend AnnouncementAnalyst ForecastBDXBecton, Dickinson and Company4.6572 of 5 stars$192.53-0.5%$211.44+9.8%-16.3%$55.46B$20.18B34.6374,000Positive NewsIDXXIDEXX Laboratories4.3131 of 5 stars$652.11-0.9%$644.67-1.1%+34.1%$52.65B$3.90B54.3011,000News CoveragePositive NewsAnalyst ForecastInsider TradeEWEdwards Lifesciences4.4765 of 5 stars$78.23-0.2%$85.90+9.8%+14.9%$46.00B$5.44B11.2615,800Positive NewsAnalyst RevisionRMDResMed4.6537 of 5 stars$284.33+0.2%$274.83-3.3%+25.3%$41.63B$5.15B29.909,980Positive News Related Companies and Tools Related Companies ReShape Lifesciences Alternatives Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives IDEXX Laboratories Alternatives Edwards Lifesciences Alternatives ResMed Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RMTI) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access